Your browser doesn't support javascript.
loading
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.
Carlo-Stella, Carmelo; Zinzani, Pier Luigi; Sureda, Anna; Araújo, Luis; Casasnovas, Olivier; Carpio, Cecilia; Yeh, Su-Peng; Bouabdallah, Krimo; Cartron, Guillaume; Kim, Won Seog; Cordoba, Raul; Koh, Youngil; Re, Alessandro; Alves, Daniela; Chamuleau, Martine; Le Gouill, Steven; López-Guillermo, Armando; Moreira, Ilídia; van der Poel, Marjolein W M; Abbadessa, Giovanni; Meng, Robin; Ji, Ran; Lépine, Lucie; Saleem, Rao; Ribrag, Vincent.
Affiliation
  • Carlo-Stella C; Department of Biomedical Sciences, Humanitas University and Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Milano, Italy.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli" and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
  • Sureda A; Institut Català D'Oncologia - Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Araújo L; Universitário de Coimbra, Coimbra, Portugal.
  • Casasnovas O; Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France.
  • Carpio C; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Yeh SP; China Medical University Hospital, Taichung, Taiwan.
  • Bouabdallah K; Hematology and Cellular Therapy Department, University Hospital of Bordeaux, Bordeaux, France.
  • Cartron G; Department of Hematology, Centre Hospitalier Universitaire Montpellier, Montpellier, France.
  • Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
  • Cordoba R; Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Re A; Hematology Division, ASST Spedali Civili Brescia, Brescia, Italy.
  • Alves D; Hematology and Bone Marrow Transplant Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte (CHULN), Lisbon, Portugal.
  • Chamuleau M; Department of Hematology, Cancer Center Amsterdam, on behalf of the LLPC (Lunenburg Lymphoma Phase I/II Consortium), Amsterdam University Medical Center, VU University Amsterdam, Amsterdam, The Netherlands.
  • Le Gouill S; Department of Hematology, Institut Curie, Paris, France.
  • López-Guillermo A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Moreira I; Department of Onco-Hematology, Portuguese Institute of Oncology of Porto, Porto, Portugal.
  • van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, on behalf of the LLPC (Lunenburg Lymphoma Phase I/II Consortium), Maastricht University Medical Center, Maastricht, the Netherlands.
  • Abbadessa G; Sanofi, Cambridge, Massachusetts, USA.
  • Meng R; Sanofi, Cambridge, Massachusetts, USA.
  • Ji R; Sanofi, Cambridge, Massachusetts, USA.
  • Lépine L; Sanofi, Chilly-Mazarin, France.
  • Saleem R; Sanofi, Cambridge, Massachusetts, USA.
  • Ribrag V; Département d'Hématologie et Département des Essais Précoces (DITEP), Institut Gustave Roussy, Villejuif, France.
Hematol Oncol ; 41(1): 108-119, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36251503
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Lymphoma, T-Cell, Peripheral / Lymphoma, Large B-Cell, Diffuse Type of study: Clinical_trials Limits: Humans Language: En Journal: Hematol Oncol Year: 2023 Document type: Article Affiliation country: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Lymphoma, T-Cell, Peripheral / Lymphoma, Large B-Cell, Diffuse Type of study: Clinical_trials Limits: Humans Language: En Journal: Hematol Oncol Year: 2023 Document type: Article Affiliation country: Italia